Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series.
Hiroki TashiroKoichiro TakahashiYuki KuriharaHironori SadamatsuYuki KuwaharaShinya KimuraNaoko Sueoka-AraganePublished in: Journal of asthma and allergy (2022)
Anti-IL-5 agents might be alternatives for treating ICEP patients with frequent relapses.